See Credit Details Below
The COVID-19 pandemic prompted the FDA to take the extraordinary step of exercising its Emergency Use Authorization powers to help fight the spread of the virus. What is EUA, and how does it work? Join our expert faculty of life sciences practitioners, in-house counsel, government regulators, and prosecutors as we examine the current state of life sciences law and what the future might hold. This program will cover the explosive growth of digital health and the legal issues that come with it; the latest regulatory developments at the FDA; as well as recent trends in pricing and reimbursement, effective compliance and investigation practices, and enforcement.
What You Will Learn
• The FDA and COVID-19
• Learn about Recent Developments in Digital Health
• Examine Enforcement Trends impacting the Drug and Device Industries
• The Public Readiness and Emergency Preparedness Act (PREP Act)
• Review Effective Compliance Programs and Investigations
Program Level: Overview
Intended Audience: Attorneys and allied professionals who counsel pharmaceutical and life sciences companies.
Prerequisites: An interest in the law and business of pharmaceutical and life sciences companies.
Advanced Prep: None